For instance, legislators like Sens. Elizabeth Warren of Massachusetts, Bernie Sanders of Vermont, and Jeff Merkley of Oregon recently warned that Cures amounts to a big pharma giveaway which will weaken regulatory standards on drugs, provide a mere pittance to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), and do nothing to confront the rising tide
of high drug prices.
Not exact matches
That trajectory that will surprise no one who follows the news, or the bipartisan campaign - season bashing
of the nation's sky -
high prescription
drug prices.
House Democrats push for explanation
of high MS
drug prices.
A 2012 report by the Kaiser Family Foundation calls the PBM assertions
of Medicare savings «overstated» and says the reduced cost probably stemmed from incorrectly
high predictions
of prices and from brand
drugs going generic.
Soliris's
price can run as
high as $ 700,000 a year, with the
drug accounting for the bulk
of Alexion's $ 3 billion in 2016 sales.
Gottlieb suggested that this opaque structure ultimately leads to
higher costs by thwarting competition, and argued for broader adoption
of «biosimilar»
drugs to bring down
drug prices.
Trump appears to be simultaneously criticizing inversion mergers that shift
drug companies» tax domiciles overseas, pharma's tactic
of using manufacturing plants in European, Asian, and African countries, and
high drug prices.
Tree — who said the policy change restored a
price support for growers by reintroducing a «federal risk premium» — told Business Insider that while consumers in states were marijuana was legal were probably used to a
high - quality and tested product, he suspected cracking down on legal marijuana production and sales would incentivize trafficking
of lower - quality marijuana to states where the
drug is still illegal.
President Donald Trump sat down with a host
of major pharma company CEOs Tuesday morning to address pressing issues like
high drug prices, the future
of the FDA, and where treatments are produced.
The debate over
high drug prices has been a red hot topic here and inspired a lot
of anger and legislative threats, especially in the midst
of the 2016 election cycle.
Democratic presidential contender Hillary Clinton, who has made
high drug prices a recurring target in her campaign, vowed to prevent
price hikes like Mylan's through an «aggressive new set
of enforcement tools» last week.
Admitting that «
drug prices are too
high,» Wichmann pointed to UnitedHealth's efforts to make pharmaceuticals more affordable for everyday consumers through point -
of - service discounts.
When you have these kinds
of price hikes, which in some cases I believe are just simply criminal and they are done because
of greed, it's like putting a gun to somebody's head and saying you need to pay me this very
high price for the
drug or you die.
More health plans and employers are signing up with pharmacy benefit managers like CVS Health (cvs) and Express Scripts (esrx), which control the list
of drugs those insurance plans will cover, increasingly restricting patients from taking unreasonably
high -
priced drugs.
He jawboned Carrier into keeping jobs in the United States, threatened Boeing for the cost
of Air Force One and Lockheed on its F - 35 aircraft, and pharmaceutical companies on their
high drug prices.
The president followed up later in the day, tweeting that Merck «is a leader in
higher &
higher drug prices while at the same time taking jobs out of the U.S. Bring jobs back & LOWER PRICES!&
prices while at the same time taking jobs out
of the U.S. Bring jobs back & LOWER
PRICES!&
PRICES!»
Herper homes in on a relatively new class
of super-powerful (and super expensive) cholesterol - busting
drugs called PCSK9 inhibitors (which were just shown to reduce death from any cause, and particularly heart - related conditions), and how patients with staggeringly
high cholesterol who would benefit from the treatments had to wrangle with insurance companies that refused to cover them over their
high prices.
Competitive bidding could very well be an effective way
of fighting sky -
high drug prices that are taking a toll on patients and their families.
While some responders had particular axes to grind (it's true that U.S.
drug prices are radically
higher than elsewhere in the world, for instance, and maybe a gamma ray burst could destroy earth, but those aren't really things you can act on tomorrow), many more offered healthful reality checks that most
of us could benefit from, including:
«I hold physicians to a
higher standard,» Bourdette said, noting that some alternatives to Acthar cost 1 / 50th
of the
drug's
price.
The April 26 memo comes just one day before three
of Valeant's top executives are slated to appear before a different U.S. Senate panel that is also investigating
high drug prices.
I hope so, particularly in light
of pharmaceutical companies frequently pointing to the
high costs
of developing new
drugs as being the primary reason
prices are so
high for existing
drugs.
The
price of insulin — a lifesaving
drug — has reached record
highs as Eli Lilly, Novo Nordisk and Sanofi raised
prices more than 240 percent over the past decade to often over $ 300 a vial today, with
price rises frequently in lockstep, according to information technology firm Connecture.
Valeant became the face
of high American
drug prices when it acquired Isuprel and Nitropress last year and immediately raised their
prices by 525 percent and 212 percent.
Months after Valeant Pharmaceuticals International Inc. said it would make discounts available to U.S. hospitals for two
high -
priced heart
drugs, some medical centers say they have yet to see a cent
of savings.
Why should we expect Mylan or any other pharmaceutical company to refrain from yanking up the
price of lifesaving
drugs as
high as the market will bear?
To this end, we have patent laws that make developers
of new
drugs the only legal sellers, and hence make it possible for them to charge
high prices.
While
high price tags are common for rare disease
drugs, Emflaza is part
of a class
of drugs called corticosteroids that are used for DMD in other parts
of the world.
That's because plans increasingly carry
high deductibles, which require patients to pay for their
drug costs themselves until they hit a certain limit, as well as to pay a percentage
of the list
price even after their deductible is met.
Mr. Fein said that because the fastest - growing part
of the pharmacy industry was
high -
priced specialty
drugs for people who have considerable medical needs, «it makes sense to manage those within one coordinated organization.»
The pharmaceutical industry is typically reluctant to talk about U.S.
drug prices, generally the
highest in the world due to a combination
of market fragmentation and free market policies.
Although some
price increases have been caused by shortages, others have resulted from a business strategy
of buying old neglected
drugs and turning them into
high -
priced «specialty
drugs.»
Trump lashed out quickly at Frazier on Twitter after the announcement, accusing the drugmaker
of being «a leader in
higher &
higher drug prices while at the same time taking jobs out
of the U.S.»
While most
of the attention on pharmaceutical
prices has been on new
drugs for diseases like cancer, hepatitis C and
high cholesterol, there is also growing concern about huge
price increases on older
drugs, some
of them generic, that have long been mainstays
of treatment.
The stock
prices of most
drug related companies have been suppressed a bit recently as a result
of politicians voicing their opinions about
high drug prices.
Wells Fargo Securities LLC's David Maris told clients in a note, «We believe that there is a
high risk that healthcare and
drug pricing will be a key part
of the midterm elections as well as the next presidential election, and we expect that the current administration will try to blunt any criticism that it hasn't done enough with plans
of its own before then.»
Celgene's lead product, Revlimid, a
drug designed to treat multiple myeloma and a few other cancer types, has been benefiting from longer duration
of use, strong
pricing power, and
high multiple myeloma market share.
But its business model, which has also relied on aggressive
price hikes for acquired
drugs, has come under growing scrutiny because
of political backlash against
high drug prices, dragging Valeant shares down from record
highs scaled in August.
Price segregation allows vital
drugs to be provided at cost (or closer to it) for low - income nations, while American customers pay
high enough
prices to fund research and development
of new medications.
Of course the price of drugs go sky hig
Of course the
price of drugs go sky hig
of drugs go sky
high.
The other driver
of high US
drug prices is a lack
of bargaining power.
Sanders is one
of the most outspoken members
of the Democratic caucus against
high drug prices and the pharmaceutical industry.
Last year, as pressure mounted on the pharmaceutical industry after a series
of high profile cases involving skyrocketing
prices,
drug companies spent roughly $ 800,000 lining campaign coffers in Albany.
Meanwhile, Cuomo ended his three - day State
of the State tour Wednesday with a speech in Albany that featured a renewed call for ethics reform and a proposal designed to cap the sky -
high prices of prescription
drugs in New York.
The public should demand that Big Pharma immediately disgorge some
of their profits, stop charging Americans the
highest prices in the world, and create a fund to pay for research on
drugs that can curb the spread
of infectious diseases.
After controlling for other factors, a generic
drug in the
highest marketing competition group was expected to see a decrease
of 32 percent in
price over the study period, while a generic
drug in the lowest market competition was expected to see a
price increase
of 47 percent over the same period.
Recent studies by Sood and colleagues at USC Schaeffer Center, the USC
Price School
of Public Policy and the USC School
of Pharmacy have found that most consumers on
high - deductible plans are not comparing
prices to find the best deals on services or on prescription
drugs, even though the research indicates that some patients could potentially save hundreds or thousands
of dollars per year.
Michael
Price, 13 April
Drug development companies are now hiring more computational biologists, creating an abundance
of high - paying jobs.
The benefits
of catching psychosis early were deemed to come at too
high a
price — over-reliance on antipsychotic
drugs which have unpleasant side effects
Other recommended actions include more research, especially collaborative work, and more funding for that research; practicing integrity and
high ethics; and controlling costs in such a way as to reduce the
prices of drugs.